These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16005162)

  • 1. Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users.
    Zacny JP
    Drug Alcohol Depend; 2005 Nov; 80(2):273-8. PubMed ID: 16005162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers.
    Zacny JP
    Psychopharmacology (Berl); 2003 Jan; 165(2):146-56. PubMed ID: 12404072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users.
    Zacny JP; Gutierrez S; Bolbolan SA
    Drug Alcohol Depend; 2005 Jun; 78(3):243-52. PubMed ID: 15893155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
    Zacny JP; Conley K; Marks S
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1159-69. PubMed ID: 9067299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.
    Preston KL; Wolf B; Guarino JJ; Griffiths RR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):707-20. PubMed ID: 1501118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers.
    Zacny JP; Hill JL; Black ML; Sadeghi P
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1197-207. PubMed ID: 9732379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers.
    Zacny JP; Conley K; Galinkin J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1187-97. PubMed ID: 9316825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the abuse potential of methocarbamol.
    Preston KL; Guarino JJ; Kirk WT; Griffiths RR
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1146-57. PubMed ID: 2703967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
    Zacny JP; Gutierrez S
    Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers.
    Zacny JP; Gutierrez S
    Psychopharmacology (Berl); 2003 Nov; 170(3):242-254. PubMed ID: 12955305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers.
    Walker DJ; Zacny JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1454-64. PubMed ID: 10336539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers.
    Zacny JP; Lichtor JL; Thapar P; Coalson DW; Flemming D; Thompson WK
    J Pharmacol Exp Ther; 1994 Aug; 270(2):579-88. PubMed ID: 8071850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers.
    Zacny JP; Goldman RE
    Drug Alcohol Depend; 2004 Feb; 73(2):133-40. PubMed ID: 14725952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers.
    Zacny JP; Lichtor JL; Flemming D; Coalson DW; Thompson WK
    J Pharmacol Exp Ther; 1994 Jan; 268(1):1-9. PubMed ID: 8301543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
    Zacny JP; Gutierrez S
    Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.
    Marsch LA; Bickel WK; Badger GJ; Rathmell JP; Swedberg MD; Jonzon B; Norsten-Höög C
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1056-65. PubMed ID: 11714895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.